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Abstract
Aldehyde dehydrogenase (ALDH) 2 is a mitochondrial isozyme of the heart involved in the
metabolism of toxic aldehydes produced from oxidative stress. We hypothesized that
hyperglycemia-mediated decrease in ALDH2 activity may impair mitochondrial respiration
and ultimately result in cardiac damage. A single dose (65 mg/kg; i.p.) streptozotocin injec-
tion to rats resulted in hyperglycemia with blood glucose levels of 443 ± 9 mg/dl versus 121
± 7 mg/dl in control animals, p<0.0001, N = 7–11. After 6 months of diabetes mellitus (DM)
induction, the rats were sacrificed after recording the functionality of their hearts. Increase
in the cardiomyocyte cross sectional area (446 ± 32 μm2 Vs 221 ± 10 μm2; p<0.0001) indi-
cated cardiac hypertrophy in DM rats. Both diastolic and systolic dysfunctions were
observed with DM rats compared to controls. Most importantly, myocardial ALDH2 activity
and levels were reduced, and immunostaining for 4HNE protein adducts was increased in
DM hearts compared to controls. The mitochondrial oxygen consumption rate (OCR), an
index of mitochondrial respiration, was decreased in mitochondria isolated from DM hearts
compared to controls (p<0.0001). Furthermore, the rate of mitochondrial respiration and
the increase in carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-induced
maximal respiration were also decreased with chronic hyperglycemia. Chronic hyperglyce-
mia reduced mitochondrial OXPHOS proteins. Reduced ALDH2 activity was correlated
with mitochondrial dysfunction, pathological remodeling and cardiac dysfunction, respec-
tively. Our results suggest that chronic hyperglycemia reduces ALDH2 activity, leading to
mitochondrial respiratory dysfunction and consequently cardiac damage and dysfunction.
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Introduction
Hyperglycemia, the increase in blood glucose levels, is a common symptom of both type-1 and
type-2 diabetes mellitus (DM). Though the etiopathogenesis is different for both types [1–4],
proper control of blood glucose levels is necessary to avoid severity of diabetic complications in
both types of diabetic patients [1, 5–8]. The morbidity and mortality of diabetic patients is
associated with cardiovascular complications, with percentages as high as 44% [9] and 65%
[10] in type-1 and type-2 diabetes, respectively. Chronic hyperglycemia-induced oxidative
stress is considered to be one of the major causes of diabetic cardiovascular complications [11,
12]. Therefore, understanding the molecular pathogenesis of hyperglycemia-induced oxidative
stress in the myocardium would be beneficial for diabetics in general.
Hyperglycemia-inducedoverproduction of reactive oxygen species (ROS) by the mitochon-
drial electron-transport chain is a key aspect of the pathogenesis of diabetic cardiac damage [13].
Oxidative stress-inducedROS increases the generation of toxic reactive aldehydes such as
4-hydroxy-2-nonenal (4HNE) in the mitochondria [14]. Additional 4HNE then forms adducts
with proteins, leading to cardiac damage [15, 16]. 4HNE is metabolizedby aldehyde dehydroge-
nases (ALDHs) into 4-hydroxy-2-nonenoic acid (4HNA), a non-toxic acid [17]. ALDH2, the
mitochondrial isoform of ALDH, plays an important role in detoxifying 4HNE, further protecting
the heart from oxidative stress/injury [18, 19]. Reduced activity and levels of myocardial ALDH2
were reported in type-1 diabetic hearts [20, 21]. Recently, we found that 4HNE forms adducts
with ALDH2 itself and attenuates its activity, thereby contributing to cardiac hypertrophy in a
non-geneticmodel of type-2 DM [15]. Overexpression of ALDH2 conferred cardio protection in
STZ-injected diabeticmice [20]. ALDH2 overexpression attenuated the decrease or drop inmito-
chondrial membrane potential [20]. ALDH2 activation by a small molecule activator, Alda-1, pro-
tected ischemia-reperfusion inducedmyocardial injury. Particularly, this compound was known
to attenuate 4HNE-inducedALDH2 impairment [19]. In summary, ALDH2 activity seems to be
vital in preventing 4-HNE-induced cardio toxicity irrespective of origin of the diseases.
Earlier it was reported that 4HNE adduct formation inhibits activity of cytochrome c oxidase
(COX IV), a mitochondrial respiratory complex IV protein, and leads to myocardial injury with
ischemia-reperfusion[16]. Similarly, 4HNE adduct formation with succinyl dehydrogenase
(SDH) in the STZ-induced type-1 diabetic heart leads to inhibition of mitochondrial respiratory
complex II activity [22]. In another study, 4HNE treatment attenuated mitochondrial respiration
in cultured neonatal cardiomyocytes. Exhaustion of mitochondrial respiratory reserve capacity in
cells puts them at risk of succumbing to oxidative stress [23]. All these studies demonstrate that
4HNE plays an important role in mitochondrial respiratory dysfunction in cardiac pathologies.
Based on these reported findings, we hypothesized that enhanced 4HNE levels and reduced
ALDH2 activity lead to mitochondrial respiratory dysfunction and ultimately cardiac damage
and dysfunction in DM. To test this hypothesis, we employed a rat model of streptozotocin
(STZ)-induced chronic hyperglycemia. This model presents hyperglycemia, myocardial 4HNE
accumulation, and cardiac damage; therefore it is suitable to test our hypothesis. Moreover this
model is simple, easily reproducible and most importantly, it produces hyperglycemia as early
as 2 days and remains elevated until several months, thus mimicking chronic hyperglycemia in
type-1 diabetic patients without other co-morbid factors for cardiac diseases.
Materials and Methods
Induction of hyperglycemia
Hyperglycemia was induced in 8-week-oldmale Sprague-Dawley rats by administering a single
intraperitoneal (i.p.) injection of streptozotocin (STZ) (65 mg/kg). It was prepared freshly in
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citrate buffer (pH 4.5) for maximal stability. The control group was injected with the vehicle
only. To ensure that the animals were diabetic, after 48 hours of STZ injection, rats were fasted
for 6 hours and their blood sample was collected from their tail veins and their glucose levels
were measured with a glucometer. Rats with blood glucose values of>250 mg/dL 48 hrs after
STZ injection were considered as diabetic and included in the study.
The animal protocol has been approved by the Henry Ford Health System Institutional Ani-
mal Care and Use Committee. It adheres to the guiding principles of the care and use of experi-
mental animals in accordance with the NIH guidelines. Henry Ford Hospital operates on an
AAALAC certifiedanimal facility with licensed veterinarian and well-trained veterinary tech-
nicians. The rats were housed in our animal facility and provided with normal chow and 24
hour water access. On the day of STZ injection, the rats were provided with sucrose water to
avoid hypoglycemia. Since diabetic animals urinate enormously, the beddingwas changed fre-
quently than control rats. The rats were housed in a separate and designated-restricted room
immediately after STZ until they excrete urine completely and later moved to normal rooms.
Six months after DM induction, we assessed cardiac function by hemodynamic
measurements.
At the end of the experiments, rats were anesthetized with sodiumpentobarbital (50 mg/kg,
i.p.), the chest opened and heart excised. The hearts were weighed, and stored appropriately at
-80°C. A portion of fresh heart tissue was used to isolate mitochondria. The middle portions of
the cardiac tissue were fixed with 10% formalin in PBS, embedded in paraffin as blocks, and
several transverse sections were cut for histopathological studies.
Mitochondrial isolation and measurement of oxygen consumption rate
(OCR) in the isolated rat heart mitochondria
Reagent and solution preparation. Mitochondria isolation buffer (IBc): 10 ml of 0.1 M
Tris–MOPS and 1 ml (0.1 M) of EGTA/Tris to 20 ml of 1M sucrose. The pH was adjusted to
7.4 and the volume was made to 100 ml with distilledwater.
Components / formulation of mitochondrial assay solution-1 (MAS). Sucrose 70 mM,
mannitol 220 mM, KH2PO4 5mM,Mgcl2 5mM, HEPES 2 mM, EGTA 100 mM, fat free BSA
2%. MAS was prepared for the dilution of substrates, ADP and respiration reagents. Stocks of
succinate (0.5 M) and ADP (0.5 M) were made in H2O and adjusted to pH 7.2 with potassium
hydroxide. Stocks of 2.5 mM FCCP [carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone],
2.5 mM rotenone, 2.5 mM oligomycin and 2.5 mM antimycin A were made in DMSO and
stored at -20°C.
CMST (CellMito Stress Test) media for cell bioenergeticmeasurements. 1% glucose
along with 1 mM sodium pyruvate and 2 mMGlutaMAX were added to the XF medium (Sea-
horse Bioscience).
Isolation of rat heartmitochondria. After hemodynamicmeasurements, approximately
400 mg of heart tissue was harvested and homogenized in mitochondrial buffer (IBc). This
homogenate was centrifuged at 2000 RPM for 10 min at 4°C and the supernatant was collected
and again centrifuged at 5000 RPM for 10 min at 4°C. The sedimentedmitochondrial pellet
was re-suspended in 50 μl of mitochondrial buffer. Mitochondrial protein was measured by
means of Bradford assay and 4 μg of mitochondrial protein was added to each well of a colla-
gen-coated plate. The plate was transferred to a centrifuge equipped with a swinging bucket
microplate adaptor and spun at 2000 g for 20 minutes at 4°C. ADP, Oligomycin, FCCP and
Antimycin A were loaded sequentially through ports in the Seahorse XFe96 FluxPak cartridge.
The cartridge and the mitochondria coated plate were then transferred to the XFe96 Extracellu-
lar Flux Analyzer (Seahorse Bioscience) and the experiment was initiated.
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ALDH activity assay
ALDH2 activity was measured by the procedure described elsewhere [15, 19]. In brief, enzy-
matic activity of ALDH2 from cardiac tissue homogenate was determined spectrophotometri-
cally by the reductive reaction of NAD+ to NADH at λ340 nm. All assays were carried out at
25°C in 0.1M sodium pyrophosphate buffer, pH = 9.5 with 2.4 mMNAD+ as a cofactor and 10
mM acetaldehyde as the substrate.
Western blotting of 4HNE protein adducts and mitochondrial OXPHOS
proteins
TheWestern blot was performed as described earlier [24, 25]. In brief, protein samples from
cardiac homogenate were separated on SDS-polyacrylamide gels by electrophoresis and the
proteins were then transferred to immobilon-Pmembranes (Millipore, Billerica,MA). Levels
of 4HNE-protein adducts in heart samples were determined using antibodies of anti-
4HNE-Cys/His/Lys rabbit antibody (Millipore) (at a concentration of 1:1000) and Total
OXPHOS rodent WB Antibody Cocktail (Abcam) at a concentration of 1:15000. Porin mouse
monoclonal antibody at a concentration of 1:2000 (Abcam) was used as a housekeepingmarker
for comparison. The bound antibody was visualizedwith horseradish peroxidase (HRP)-cou-
pled, secondary antibody, and chemiluminescencedetection reagents.
Co-immunoprecipitation of ALDH2 with phospho antibodies
Co-immunoprecipitation (IP) studies were performed as we described earlier [26]. An anti-
pSer/Thr (phe) antibody (CST Inc) was crosslinked to dimethyl pimelimidate as per Abcam
Inc protocol. The cross linked antibody was used in normal co-IP protocol. Briefly, we used
cardiac tissue protein (500ug) in a final volume of 200 μL and incubated it for 2 hours. Then
protein-A/G agarose beads (Santa Cruz) were added to each sample and rocked at 4°C over-
night. The beads were washed several times and then re-suspended in IP buffer. The samples
were immunoblotted against the anti-ALDH2 antibody.
Measurement of cardiomyocyte hypertrophy
Myocardial sections were stained with hematoxylin-eosin staining to measure cardiomyocyte
hypertrophy. The details were mentioned in our previous study [15]. In brief, cardiomyocytes
with a relatively circular shape and a centered nucleus were included for quantification of each
high power field. The cross sectional area was measured for these cardiomyocytes.We scored
at least 15 photomicrographs for each sample.
Measurement of cardiac fibrosis
The myocardial sections were stained with Picrosirius red. The red color indicates the deposi-
tion of collagen and this area was measured using the MicroSuite software (Olympus America).
The percent (%) area of fibrosis was quantified from each tissue section as previously described
[27].
Cardiac functional assessment by echocardiography
After 6 months of induction of the diabetes, the left ventricular dimension and functionwere
assessed in anesthetized rats (1–2% isoflurane) using an echocardiograph equipped with a
15-MHz linear transducer (Acuson c256), as describedpreviously [15].
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Cardiac function assessment by hemodynamic measurements
Cardiac functionwas assessed by using the Millar Mikro-Tip Pressure Catheter, SPR-320
(ADInstrumnts, Australia) as reported earlier by our lab [15]. In brief, the Millar catheter was
inserted into the left ventricle of the rat via the right carotid artery to assess left ventricular
pressure (LVP) and the peak and minimum values of LV dP/dt (LV dP/dtmax and LV dP/
dtmin, respectively) under the influence of an anesthetic, Inactin (100 mg/kg i.p.). Hemody-
namic parameters were recorded after stabilization for 30 min, using an eight-channel lab
recorder (ADInstruments, Australia) containing LABCHART-7 software.
Correlation analysis
A linear regression analysis betweenALDH2 activity and mitochondrial function, ALDH2
activity and cardiac hypertrophy and fibrosis, and ALDH2 activity and systolic and diastolic
dysfunctionwas performed. Individual correlation graphs were then plotted.
Statistical analysis
Data are presented as mean ± standard error of the mean (SEM). To confirm the data is nor-
mally distributed, we used a non-parametricMann-Whitney test in addition to Student t test
using Graphpad Prism 5. Statistical significancewas achieved when p was<0.05.
Results
Streptozotocin-induced chronic hyperglycemia decreased ALDH2
activity and levels and showed an increase in 4HNE protein adducts in
rat hearts
A single dose (65 mg/kg; i.p.) injection of STZ resulted in hyperglycemia, as evident from
increased blood glucose levels {443 ± 9 mg/dl in DM versus 121 ± 7 mg/dl in control animals}
within a week, which persisted for 6 months. The chronic hyperglycemia resulted in a 50%
decrease in body weight relative to control rats.
Most importantly, myocardial ALDH2 activity (Fig 1A) and levels (Fig 1B and 1C) were
reduced and 4HNE protein adduct levels (Fig 1D and 1E) were increased in diabetic hearts
compared to control hearts.
Reduction in mitochondrial respiration, their reserve capacity and levels
of mitochondrial OXPHOS protein subunits of respiratory complex
proteins in diabetic rat myocardium
The mitochondrial oxygen consumption rate (OCR), an index of mitochondrial respiration,
was decreased in mitochondria isolated from diabetic hearts compared to controls. We calcu-
lated mitochondrial basal OCR (ΔOCR from basal minus Antimycin-A; {122 ± 14 (control) vs
65 ± 6 (DM)} (Fig 2A), ADP OCRADP minus Oligomycin; {128 ± 15 (control) vs 76 ± 8
(DM)} (Fig 2B), and maximumOCRFCCPminus Antimycin-A; {135 ± 21 (control) vs
76 ± 12 (DM)} (Fig 2C).
Most strikingly, the mitochondrial respiratory reserve capacity with FCCP (AUC OCR)was
significantly decreased in the diabetic group with chronic hyperglycemia (860 ± 130) compared
to the control group (2001 ± 429) (Fig 2D). Finally, the respiratory control rate (RCR) of state
III/state IV was also significantly reduced in the diabetic group (1.5 ± 0.1) compared to the
control group (2.2 ± 0.2) (Fig 2E). The RCR is a bit low even in the control groups, perhaps due
to the old age of the rats (Fig 2E).
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Fig 1. Change in myocardial ALDH2 levels, activity and 4HNE protein adducts. A. ALDH2 activity. The data expressed are mean ± SEM. N = 5–6 rats.
* p<0.05 vs. Control. B. Western blot images of ALDH2 and porin. Porin, a mitochondrial protein, was used as a loading control to normalize mitochondrial
ALDH2. C. The densitometry quantification data of ALDH2/porin. Protein lysates of cardiac homogenates were used for measuring ALDH2 levels by
Western blotting in DM and control rats. The data expressed are mean ± SEM. N = 5–6 rats. * p<0.05 vs. Control. D. Western blot images of 4HNE adducts
and porin. E. The densitometric quantification data of 4HNE protein adducts/porin. The data expressed are mean ± SEM. N>3 rats. * p<0.05 vs. Control.
doi:10.1371/journal.pone.0163158.g001
Fig 2. Mitochondrial respiration indices. Mitochondrial oxygen consumption rate (OCR) of control and DM rats: A) Mitochondrial basal OCR (ΔOCR
from basal minus of Antimycin-A). B) ADP OCR (ADP minus Oligomycin). C) Maximum OCR (FCCP minus Antimycin-A). D) FCCP-induced
mitochondrial respiratory reserve capacity. (Area under curve of FCCP minus area under curve oligomycin) was plotted as a graph. E) The ratio
between state 3 and 4 respirations was depicted as the respiratory control rate (RCR). The data expressed are mean ± SEM. N = 6–11. ** p < 0.01 vs
control;.***P<0.0001 vs control.
doi:10.1371/journal.pone.0163158.g002
ALDH2 Inactivity and Mitochondrial Dysfunction
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DM also reduced the levels of mitochondrial OXPHOS protein subunits of respiratory
complex proteins (Fig 3A–3F). Specifically, ETC complex protein subunits NADH dehydro-
genase (ubiquinone) 1 beta sub complex 8 (NDUFB8; complex I), succinate dehydrogenase
complex, subunit B, iron sulfur (SDHB/Ip; complex II), ubiquinol-cytochrome c reductase
core protein II (UQCR2; complex III), and cytochrome c oxidase subunit 2 (COXII; complex
IV) were significantly reduced. ATP synthase 5A (ATP 5A, Complex V) was not decreased in
DM.
Chronic hyperglycemia increased pathological cardiac hypertrophy and
fibrosis
There were increases in the cardiomyocyte cross sectional area (Fig 4A, 4B and 4C) and heart
weight to body weight ratio (Fig 4D). Thus, cardiac hypertrophy was found in diabetic rats ver-
sus in control rats. Furthermore, increase in cardiac fibrosis was evident from increased colla-
gen deposition (Fig 4E, 4F and 4G) with Picrosirius red in the diabetic cardiac sections
compared to cardiac sections of the control group.
Fig 3. Levels of mitochondrial complex proteins. A). Western blot images of mitochondrial OXPHOS respiratory complex protein levels and
VDAC (Porin) were shown in DM compared to control. A cocktail antibody comprising the following subunits of respiratory complex proteins are
used: NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (NDUFB8; complex I), succinate dehydrogenase complex, subunit B, iron sulfur
(SDHB/Ip; complex II), ubiquinol-cytochrome c reductase core protein II (UQCR2; complex III), cytochrome c oxidase subunit 2 (COXII; complex
IV) and ATP synthase 5A (ATP 5A, Complex V). B, C, D, E and F). Quantification of the levels of each of the above mentioned subunits were
shown, respectively. The data was presented as % of proteins normalized to porin levels.
doi:10.1371/journal.pone.0163158.g003
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Chronic diabetes reduced cardiac performance in streptozotocin-
injected rats
The cardiac performancewas reduced in diabetic rats compared to controls. As listed below in
detail: 1) Fractional shortening was reduced to 35% in the diabetic condition from a control value
of 45% (S1A and S1B Fig) 2) Left ventricular dimensions during systole and diastole (S1C and
S1D Fig) were also increased in diabetic rats compared to control rats. 3) A 42% decrease in E/A
ratio was recorded with the diabetic condition compared to the normal control (S2A and S2B
Fig). 4) Left ventricular systolic pressure was reduced in the DMmodel compared to the control
{97 ± 4 mmHg in diabetic group versus 129 ± 5% in the controls (S3A and S3B Fig)}. 5) Heart
rate was lower in the diabetic heart (281 ± 9 beats perminute) compared to the control. (343.5 ±
12 beats perminute) (S3C Fig). 6) Left ventricular end diastolic pressure (LVEDP), a measure of
diastolic function,was increased in the hyperglycemic condition (14.2 ± 1.1 mmHg) compared
to the normal condition (8 ± 1.5 mmHg) (S3D Fig). 7) Peak and minimum LV dP/dt values were
also reduced in the diabetic condition and this data was presented as +dP/dt and -dP/dt (S4A
and S4B Fig).
Reduced ALDH2 activity was correlated with mitochondrial dysfunction,
pathological remodeling and cardiac dysfunction in rat diabetic myocardium
ReducedALDH2 activity was correlated with mitochondrial respiratory dysfunction {mito-
chondrial reserve capacity (Fig 5A) and maximal respiration (Fig 5B)}, pathological cardiac
Fig 4. Histopathological analysis of myocardial hypertrophy and fibrosis. A & B: Cardiomyocyte hypertrophy: Photomicrographs of cardiac
sections stained with hematoxylin-eosin from the control and DM groups were shown. The increase in cardiomyocyte size was apparent in the
DM group. N = 5–6. C. The quantification data of cardiomyocyte cross-sectional area was shown. The data expressed are mean ± SEM. N = 5–6
**p <0.01. D. Quantification of heart weight to body weight ratio. E & F. Cardiac fibrosis. Representative micrographs of cardiac sections stained
with Picrosirius red from the control and DM groups were shown. The red color area indicates collagen deposition in the heart. N = 5–6. G.
Percent (%) area of cardiac fibrosis. The collagen deposition was quantified and presented as a % area of cardiac fibrosis. The data expressed
are mean ± SEM. N = 5–6 ***p <0.0001.
doi:10.1371/journal.pone.0163158.g004
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PLOS ONE | DOI:10.1371/journal.pone.0163158 October 13, 2016 8 / 15
remodeling {cardiac hypertrophy (Fig 5C) and fibrosis (Fig 5D)} and cardiac dysfunction {%FS
(Fig 5E) and end-diastolic pressure (Fig 5F)}.
Discussion
In the present study, we found reduced ALDH2 activity correlated with decreasedmitochon-
drial respiration and their reserve capacity in the myocardium of chronic hyperglycemic rats.
Molecular biochemical studies implicate oxidative stress as an important causative factor of
diabetic complications [13, 28]. Hyperglycemia-inducedROS is reported to cause the genera-
tion of advanced glycated end products (26, 27) and reactive carbonyl compounds, including
toxic aldehydes such as 4HNE (14, 15), malondialdehyde (MDA) (28) and methylglyoxal
(MGO) (29). Several studies implicated reactive aldehydes in the pathophysiology of diabetes-
induced tissue damage including heart (14), liver (30), kidney (31) and vasculature (32). In this
study, we found increased 4HNE protein adducts in a diabetic rat myocardium. There was also
reduced ALDH2 activity in the diabetic heart which may be due to 4-HNE adduct formation
on ALDH2 as shown in a type-2 diabeticmouse model [15]. It has been shown that ALDH2
activity and levels were decreased in streptozotocin-induceddiabetes in rats [21] and mice [20,
29]. However, no one has yet exclusively studied whether this reduction contributes to defec-
tive mitochondrial respiration.
Fig 5. Correlation between ALDH2 activity and mitochondrial respiratory dysfunction, cardiac pathological remodeling and cardiac dysfunction.
Graphs showing direct correlation between ALDH2 activity with A) Respiratory reserve capacity, B) Maximum OCR and inverse correlation with C)
Hypertrophy, D) Fibrosis, E) Systolic dysfunction and F) diastolic dysfunction. Data were analyzed by linear regression (*** < 0.001, ** < 0.01, * p < 0.05).
N = 4 per group. Open and closed circles denote control and DM respectively.
doi:10.1371/journal.pone.0163158.g005
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ALDH2 has been implicated as a therapeutic target in cardiovascular diseases [30]. There
are several studies using ALDH2 knockout mice that demonstrated the importance ALDH2 in
cardio protection. For instance, at 4 weeks after MI, myocardial infarct size, cavity size and
end-diastolic pressure were significantly greater and ejection fractionwas significantly lower in
ALDH2 knockout mice than inWTmice [31]. In a model of hind limb ischemia, the perfusion
ratio was achieved 80% at the 3-week point in WTmice but only a 60% perfusion ratio was
found in ALDH2 knockout mice [32]. In both these studies, transgenic restoration of ALDH2
ameliorated the pathologies. Patients lacking ALDH2 activity due to ALDH22 mutation show
a strong association with coronary spastic angina [33]. All these studies demonstrate that
ALDH2 is very critical in cardiovascular diseases. Pertaining to our model, type-1 DM induced
diastolic dysfunction in ALDH2 knock out mice [34] while ALDH2 overexpression has been
shown to attenuate type-1 DM-induced cardiac damage in mice [20]. Even though we demon-
strate a significant correlation betweenALDH2 inactivity with mitochondrial respiratory dys-
function, pathological cardiac remodeling and cardiac contractile dysfunction, future studies
using genetic and pharmacological tools for ablation and activation of ALDH2 will strongly
reaffirm the role of ALDH2 in diabetic cardiac damage and dysfunction.
The cardioprotective effect of ALDH2 came to the limelight after ALDH2 was identified as
a target of protein kinase C (PKC) epsilon [19]; ALDH2 is phosphorylated by PKC epsilon and
this phosphorylated ALDH2 has increased activity compared to non-phosphorylated ALDH2.
There are specific phosphorylation sites identified in ALDH2 including Thr185, Thr412 and
Ser 279 after interaction with PKC-epsilon [19]. Endogenous PKC-epsilon activation was
showed to protect type-1 diabetic heart [35]. It was not determinedwhether ALDH2 phos-
phorylation was a causative factor for this effect.We anticipated a decrease in ALDH2 phos-
phorylation in our diabetic rat hearts. However, we did not find any decrease in ALDH2
phosphorylation in our samples as demonstrated by co-IP studies (S5 Fig). We speculate the
phosphorylation event may be a temporal process and we could have missed it as we test it at a
single time point (6 months of diabetes). A time course study may clarify the ALDH2 phos-
phorylation state in a time-dependentmanner in chronic DM. Reduction in ALDH2 activity in
the tissue can attenuate 4HNEmetabolism, resulting in abnormally high levels of 4HNE accu-
mulation and subsequent protein adduct formation. One of the important consequences of this
effect is increased 4HNE adduct formation in critical mitochondrial proteins involved in mito-
chondrial respiration, [36] which may cause defectivemitochondrial respiration.
As we elucidated in a review, aberrations in mitochondrial function and its regulatory pro-
cess are critical in the development of heart failure/cardiomyopathy, including diabetes-
induced cardiomyopathy/cardiac damage [37]. Mitochondrial dysfunction, such as uncoupling
of the electron transport chain and oxidative phosphorylation, results in generation of cell-
damaging ROS in vitro and in vivo. In this study, we evaluated mitochondrial respiration by
measuring the OCR of isolated mitochondria from STZ-induced diabetic and control hearts.
Specifically, we calculatedmitochondrial respiratory reserve capacity as this was implicated as
the index of oxidative stress-mediatedmitochondrial dysfunction.When we found that there
was a significant decrease in mitochondrial respiration in the diabetic condition, we suggested
that the increased 4HNE and /or reduced ALDH2 activity should be responsible. In an earlier
study by Hill et al. it was shown that 4HNE treatment in neonatal cardiomyocytes attenuated
the mitochondrial respiratory reserve capacity [23]. This, however, is the first report to impli-
cate reduced ALDH2 activity and impaired mitochondrial respiratory reserve capacity in an
animal model of diabetic cardiomyopathy. Exhaustion of the mitochondrial reserve capacity
will ultimately result in respiratory dysfunction in oxidative stress conditions. Therefore, our
study point out a new important subcellular defect that occurs in the diabetic heart, along with
ALDH2 impairment.
ALDH2 Inactivity and Mitochondrial Dysfunction
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In the diabetic heart, hyperglycemia-induced 4HNE adduct formation on ALDH2 can
reduce its activity. In turn, the reduced ALDH2 activity will lead to lowered 4HNE detoxifica-
tion. Thus a vicious cycle sets in, ultimately resulting in decreasedmitochondrial respiration,
presumably by forming adducts with critical mitochondrial complex proteins. Earlier studies
demonstrated that 4HNE specifically forms adducts with mitochondrial proteins such as α-
ketoglutarate dehydrogenase [38, 39], and inhibits NADH-linked respiration by reducing the
steady-state level of NADH in isolated cardiac mitochondria [39]. We have summarized such
findings in a recent review [14]. The oxidative phosphorylation, a key step in ATP generation
in mitochondria is carried out by a set of protein complexes in the electron transport chain.
More precisely, 4-HNE has been shown to form adducts with mitochondrial complex proteins
themselves like with succinyl dehydrogenase (SDH) in the diabetic heart [22] and cytochrome
c oxidase in the ischemic heart [16]. Similarly, in the current study, we noticed a significant
reduction in 4 mitochondrial respiratory complex proteins in diabetic hearts to varying extents.
These specific respiratory complex proteins are NADH dehydrogenase (ubiquinone) 1 beta
subcomplex 8 (NDUFB8; complex I), succinate dehydrogenase complex, subunit B, iron sulfur
(SDHB/Ip; complex II), ubiquinol-cytochrome c reductase core protein II (UQCR2; complex
III) and cytochrome c oxidase subunit 2 (COXII; complex IV). The reduction in these ETC
complex proteins in diabetes may be due to 4HNE adduct formation on them. This reduction
in the ETC complex proteins could be the reason for the lower mitochondrial respiration that
we observed in the diabetic heart.
In a model of STZ-inducedDM, occurrence of diastolic dysfunctionwas due to mitochon-
drial abnormalities such as reductions in ATP synthesis, mitochondrial Ca2+ uptake and state-
3 respiration [40]. Mitochondrial dysfunction [41, 42] was shown to contribute to myocardial
contractile abnormalities. These studies implicate that cardiac dysfunction in the myocardium
can be due to mitochondrialmalfunction.Our diabetic rats exhibited both diastolic and systolic
dysfunctionwhich should be partly due to mitochondrial respiratory malfunction that we
observed in those hearts. Further, we found reduced ALDH2 activity in the diabetic heart that
may have been linked with the poormitochondrial respiration and cardiac contractile
dysfunction.
We also observed cardiac hypertrophy and fibrosis with the chronic hyperglycemia in rat
hearts. Cardiac hypertrophy in diabeticmyocardiummay be due to increased cardiomyocyte
death. Cardiac fibrosis is another important remodeling event in the diabetic heart [43] which
was demonstrated to be enhanced by 4HNE [44, 45] and AGEs [46]. Fibrosis and hypertrophy
in the diabetic heart are major events in the pathological ventricular structural remodeling, and
will ultimately lead to diastolic and systolic dysfunction. In turn, poor contractility can fuel
progressive pathological remodeling and heart failure. Even though there are multiple stress
signals, signaling pathways and subcellular targets are proposed for these processes, ALDH2
inactivity has been correlated with pathological remodeling and poor cardiac function by us
[15] and others [21] earlier as well as in the current study. Our correlation graphs indicate the
inverse relationship betweenALDH2 activity and mitochondrial dysfunction and also with
pathological remodeling and cardiac dysfunction. Such correlation analysis point out future
directions.We believe that our study suggests chronic hyperglycemia-induced 4HNE toxicity
imparts functional changes at the organelle, cell and organ levels in the myocardium. There-
fore, removal of 4HNEmay be a potential strategy to mitigate hyperglycemia-induced cardiac
damage and dysfunction from the molecular and cellular level.
Finally, we want to conclude that chronic hyperglycemia-induced impaired ALDH2 activity
is associated at least partially for the decreasedmitochondrial respiration and ultimately
enhanced hypertrophy, fibrosis, and cardiac systolic and diastolic dysfunction in the diabetic
myocardium.
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Supporting Information
S1 Fig. Echocardiographicdata.A. M-mode echocardiographic images. Representative
echocardiographic images of control and DM groups were shown. IVS-intraventricular
septum; LVDs-Left ventricular dimension during systole; LVDd-Left ventricular dimen-
sion during diastole. B. Fractional shortening. The data expressed are mean ± SEM. N = 6
p <0.0001. C. Left ventricular dimension during systole. The data expressed are mean ±
SEM. N = 6 p <0.0001. D. Left ventricular dimension during diastole. The data
expressed are mean ± SEM. N = 6 p <0.0001
(TIFF)
S2 Fig. Trans mitral filling velocities by tissue Doppler. A. Doppler echocardiographic
images. Representative Doppler echocardiographic images of the control and DM groups. E,
early and A, late waves were identified in the image depicting diastolic filling velocities. B.
Quantification data of E/A ratio. In the ratio between early (E) and late (A) diastolic filling
velocities, the E/A ratio was plotted as a graph. The data expressed are mean ± SEM. N = 6
p<0.0001
(TIFF)
S3 Fig. Hemodynamicmeasurements.A. Tracing of a lab chart recording of the left ventricu-
lar systolic pressure. A representative tracing from control and DM rats was shown. B. The
quantification data of the left ventricular systolic pressure. The data expressed are
mean ± SEM. N = 6 p<0.0001. C. Heart rate. The data expressed are mean ± SEM. N = 6
p<0.0001. D. The quantification data of the left ventricular end diastolic pressure. The data
expressed are mean ± SEM. N = 6 p<0.0001.
(TIFF)
S4 Fig. Left ventricular systolic pressure peak and minimum (+dP/dt and -dP/dt).A. Trac-
ing of lab chart recording of the left ventricular systolic pressure peak (+dP/dt) and minimum
(-dP/dt). Representative tracings for +dP/dt and -dP/dt from control and DM rats was shown.
B. The quantification data of the left ventricular systolic pressure peak (+dP/dt) and minimum
(-dP/dt) from control and DM rats. The data expressed are mean ± SEM. N = 6 p<0.0001
(TIFF)
S5 Fig. Immunoprecipitation of anti-Pser/Thr (phe) with ALDH2. The immunoblot image
show representative control and diabetic samples along with beads with antibody and input
(+ve control).
(TIFF)
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